The Union Budget 2025-26 is expected to follow the trend of growing general government expenditure on and increasing ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...